Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Intravascular Large B-cell Lymphoma (IVLBCL)
100%
Lymphoma Patients
83%
Japanese Patients
33%
CD10
33%
No Significant Difference
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Prognostic Factors
16%
Prognostic Score
16%
Survival Curve
16%
International Prognostic Index
16%
Immunophenotyping
16%
Median Survival
16%
Poor Prognostic
16%
Systemic Symptoms
16%
Distinct Entity
16%
BCL6
16%
Immunophenotypic Profile
16%
Extranodal
16%
Germinal Center B Cells
16%
Extranodal Lymphoma
16%
Non-germinal Centre
16%
MUM1
16%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Large-Cell Lymphoma
100%
Symptom
16%
Survival Rate
16%
B Cell
16%
International Prognostic Index
16%
Germinal Center
16%
Immunophenotyping
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
100%
Large Cell Lymphoma
100%
Symptom
16%
Survival Rate
16%
Immunology and Microbiology
B Cell
100%
CD5
16%
Survival Rate
8%
Bcl-2
8%
Germinal Center
8%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
CD5
16%
Bcl-2
8%
Survival Rate
8%
Immunophenotyping
8%